ERBB2 and neoplasm: Furthermore, correct identification of tumor molecular subtype, based on the expression of hormone receptors and human epidermal growth factor receptor 2 (HER2), has been associated with receipt of guideline‐endorsed hormone therapy and chemotherapy, while correct identification of disease stage has been associated with receipt of recommended radiation therapy.5